buprenorphine and Bradycardia

buprenorphine has been researched along with Bradycardia* in 3 studies

Trials

2 trial(s) available for buprenorphine and Bradycardia

ArticleYear
Sedative and cardiopulmonary effects of buprenorphine and xylazine in horses.
    Canadian journal of veterinary research = Revue canadienne de recherche veterinaire, 2011, Volume: 75, Issue:1

    This study investigated the sedative, cardiopulmonary, and gastrointestinal effects produced by buprenorphine and xylazine given in combination to horses. Six healthy adult horses underwent 4 randomized treatments, with an interval of 1 wk between treatments. A control group was given a saline solution intravenously (IV) and the experimental groups received buprenorphine [10 μg/kg bodyweight (BW)] in combination with 1 of 3 different doses of xylazine: 0.25 mg/kg BW (BX25), 0.50 mg/kg BW (BX50), or 0.75 mg/kg BW (BX75), all of them by IV. Cardiopulmonary parameters were evaluated for 120 min after the drugs were administered and intestinal motility was observed for 12 h after treatment. Sedation was found to be dose-dependent in all groups receiving buprenorphine and xylazine and it was observed that the heart rate decreased in the first 5 min and increased at the end of the sedation period. Arterial blood gas tension analyses showed minimal alterations during the experiment. Gastrointestinal hypomotility was observed for up to 8 h. The combination of buprenorphine and 0.50 mg/kg BW of xylazine (BX50) provided a 30-minute period of sedation without intense ataxia and maintained cardiopulmonary parameters within acceptable limits for the species.

    Topics: Adrenergic alpha-2 Receptor Agonists; Analgesics, Opioid; Animals; Blood Gas Analysis; Bradycardia; Buprenorphine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Motility; Heart Rate; Horses; Hypnotics and Sedatives; Male; Respiratory Rate; Time; Xylazine

2011
Comparison of nalbuphine and buprenorphine in total intravenous anaesthesia.
    Anaesthesia, 1997, Volume: 52, Issue:11

    Nalbuphine (0.3 mg.kg-1) and buprenorphine (2.5 micrograms.kg-1) were compared as part of a total intravenous anaesthesia regimen using a propofol infusion in 60 patients undergoing laparoscopic cholecystectomy in a randomised double-blind study. Changes in haemodynamic variables greater than 20% from the baseline were noted. No difference was observed in blood pressure but the heart rate was significantly lower in the buprenorphine group. Intra-operative bradycardia (heart rate < 60 beat.min-1) occurred more often in the buprenorphine group. Recovery was fast and comparable with both drugs and no patient reported awareness. Quality of analgesia was similar in both groups. Both drugs provide suitable analgesic supplementation to total intravenous anaesthesia.

    Topics: Adult; Analgesics, Opioid; Anesthesia, Intravenous; Bradycardia; Buprenorphine; Cholecystectomy, Laparoscopic; Double-Blind Method; Drug Administration Schedule; Hemodynamics; Humans; Middle Aged; Nalbuphine; Pain, Postoperative; Patient Satisfaction; Postoperative Complications

1997

Other Studies

1 other study(ies) available for buprenorphine and Bradycardia

ArticleYear
[Severe bradycardia and hypotension during epidural anesthesia in a patient undergoing hemorrhoidectomy].
    Masui. The Japanese journal of anesthesiology, 1995, Volume: 44, Issue:1

    Severe bradycardia and hypotension developed suddenly in two patients undergoing hemorrhoidectomy under lumbar epidural anesthesia in the jackknife position, about 5 to 10 min after epidural administration of buprenorphine. Severe vago-vagal reflex was supposed to have been induced with buprenorphine in a situation where venous return was decreased by epidural anesthesia and the jackknife position.

    Topics: Anesthesia, Epidural; Bradycardia; Buprenorphine; Female; Hemorrhoids; Humans; Hypotension; Intraoperative Complications; Male; Middle Aged; Posture; Reflex, Abnormal; Vagus Nerve

1995